About
Vendela Parrow serves as a Researcher and Project Manager within the Preparative Medicinal Chemistry section of the Department of Medicinal Chemistry at Uppsala University, conducting her work at the Uppsala Biomedicinska Centrum (BMC) in Uppsala, Sweden.
Her research program centers on cancer pharmacology with emphases in drug repurposing, molecular mechanisms of anticancer agents, and immunomodulation. Key interests include investigating mebendazole's antitumor properties, MTHFD2 enzyme targeting in leukemia, macrophage polarization dynamics, and inflammasome activation pathways. This work bridges medicinal chemistry, molecular oncology, and immunopharmacology to develop novel therapeutic strategies for hematological malignancies.
Analysis of her publication record reveals a consistent focus on mechanistic pharmacology of repurposed drugs in cancer therapy, particularly exploring how compounds like mebendazole induce immunological and metabolic stress responses in tumor cells. Her research integrates biochemical, cellular, and translational approaches across pharmacology and cancer biology disciplines.
No scientific awards were documented in the provided materials.
No information regarding student mentorship or research grant funding was specified in the source documentation.
While affiliated with Uppsala University's Department of Medicinal Chemistry, specific laboratory teams or collaborative research groups were not detailed in the available information.
